Markets

  1. Home
Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Jai Hiremath

Executive Chairman

Incorporation Year

08/07/1988

Registered Address


Mumbai, Maharashtra - 400021
Tel: 022-62770299
Fax: 022-22833913

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

info@hikal.com

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal Ltd. has submitted to BSE the Shareholding Patt...

16-Jan-2026|6:00PM

As of December 2025, 68.85% is owned by Indian Promoters and 31.15% by Publ

Hikal Ltd. - Clarification - Financial Results

07-Jan-2026|6:00PM

The Exchange has sought clarification from Hikal Limited for the quarter en

Hikal Ltd. - Compliances-Certificate under Reg. 74 (5...

07-Jan-2026|12:29PM

Compliance Certificate Under Regulation 74 (5) of SEBI (DP) Regulations, 20

Hikal Ltd. - Certificate under SEBI (Depositories and...

07-Jan-2026|12:29PM

Hikal Limited has informed the Exchange about Certificate under SEBI (Depos

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug67.91192.55
Aarti Drug368.003,358.74
Aarti Pharma766.506,948.12
Abbott India27,685.0058,828.69
Accent Micro320.45768.73
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
Tata Sm..74.850.66
ICICI P..72.951.13
Tata In..8.930.68
Motilal..2.920.11
Motilal..0.020.06
More

Board Meetings

DatePurpose
13/11/2025Quarterly Results
07/08/2025Quarterly Results
14/05/2025Audited Results & F..
04/02/2025Quarterly Results &..
12/11/2024Quarterly Results
More